Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
scientific article published on 12 April 2012
Author/s
author: Michele Cavo, Giulia Perrone, Annamaria Brioli, Valerio De Stefano, Pellegrino Musto, Antonio Palumbo, Lucia Pantani, Elena Zamagni, Annalisa Pezzi, Francesca Patriarca, Catello Califano
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.